to pay a lot of money for screening for prostatic cancer even though this results in overtreatment and evidence about a possible reduction in the mortality from prostatic cancer is lacking.Therefore the initiation of new studies and extension of current studies must be stopped.A paradoxical situation exists in Belgium.Despite the European guidelines on screening for breast cancer2 the initiation of a national screening programme for breast cancer is discouraged because of insufficient support by the national and regional health authorities.On the other hand, a lot of money is spent on so called pilot projects on screening for prostatic cancer.
No takes yet. Share an insight, caveat, or question.
Hein et al. (1993) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: